CIK: 0001643354 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $19,324 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CUE | CUE BIOPHARMA INC | 2,202,854 | $673 | 3.5% | $0.61 | 0.0% | COM | 22978P106 |
| SRPT | SAREPTA THERAPEUTICS INC | 28,500 | $613 | 3.2% | $21.08 | 0.0% | COM | 803607100 |
| VTYX | VENTYX BIOSCIENCES INC | 41,500 | $375 | 1.9% | $7.47 | 0.0% | COM | 92332V107 |
| LNTH | LANTHEUS HLDGS INC | 5,500 | $366 | 1.9% | $58.19 | 0.0% | COM | 516544103 |
| DYN | DYNE THERAPEUTICS INC | 18,000 | $352 | 1.8% | $18.94 | 0.0% | COM | 26818M108 |
| QURE | UNIQURE NV | 14,700 | $352 | 1.8% | $38.59 | 0.0% | SHS | N90064101 |
| PCRX | PACIRA PHARMACEUTICALS INC | 13,500 | $349 | 1.8% | $23.78 | 0.0% | COM | 695127100 |
| VTRS | VIATRIS INC | 27,700 | $345 | 1.8% | $10.72 | 0.0% | COM | 92556V106 |
| AZTA | AZENTA INC | 9,700 | $323 | 1.7% | $32.68 | 0.0% | COM | 114340102 |
| JANX | JANUX THERAPEUTICS INC | 19,000 | $262 | 1.4% | $23.52 | 0.0% | COM | 47103J105 |
| EWTX | EDGEWISE THERAPEUTICS INC | 9,100 | $226 | 1.2% | $20.07 | 0.0% | COM | 28036F105 |
| INVA | INNOVIVA INC | 8,200 | $164 | 0.8% | $19.53 | 0.0% | COM | 45781M101 |
| IPHA | INNATE PHARMA S A | 81,151 | $142 | 0.7% | $1.75 | — | SPONSORED ADS | 45781K204 |
| NERV | MINERVA NEUROSCIENCES INC | 35,000 | $141 | 0.7% | $3.71 | 0.0% | COM NEW | 603380205 |
| GHRS | GH RESEARCH PLC | 10,200 | $130 | 0.7% | $13.62 | 0.0% | ORDINARY SHARES | G3855L106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HUMA | HUMACYTE INC | 500,000 (+498.8%) | $480 (+230.5%) | 2.5% | $1.81 | -21.6% | COM | 44486Q103 |
| BHVN | BIOHAVEN LTD | 51,700 (+127.8%) | $584 (+71.3%) | 3.0% | $24.03 | -48.4% | COM | G1110E107 |
| MIST | MILESTONE PHARMACEUTICALS IN | 755,000 (+14.6%) | $1,525 (+15.8%) | 7.9% | $2.81 | -23.4% | COM | 59935V107 |
| JSPR | JASPER THERAPEUTICS INC | 465,000 (+16.7%) | $851 (-10.3%) | 4.4% | $4.79 | -58.1% | COM NEW | 471871202 |
| GERN | GERON CORP | 578,000 (+15.6%) | $763 (+11.4%) | 3.9% | $2.17 | -42.2% | COM | 374163103 |
| MCRB | SERES THERAPEUTICS INC | 31,570 (+16.3%) | $470 (-10.0%) | 2.4% | $12.30 | +41.8% | COM NEW | 81750R201 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AVADEL PHARMACEUTICALS PLC | 59,700 | $912 | 4.7% | $11.87 | — | — | G29687103 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 23,400 | $909 | 4.7% | $18.73 | +114.1% | — | G52694109 |
| INSM | INSMED INC | 6,250 | $900 | 4.7% | $21.50 | +748.8% | — | 457669307 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | MINERALYS THERAPEUTICS INC | 10,500 (-73.1%) | $381 (-74.2%) | 2.0% | $12.41 | +223.2% | COM | 603170101 |
| PRAX | PRAXIS PRECISION MEDICINES I | 4,450 (-21.9%) | $1,312 (+334.2%) | 6.8% | $48.49 | +284.1% | COM NEW | 74006W207 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 5,250 (-85.1%) | $152 (-77.1%) | 0.8% | $10.13 | +152.7% | COM | 03969K108 |
| BBIO | BRIDGEBIO PHARMA INC | 5,000 (-62.4%) | $382 (-44.6%) | 2.0% | $27.34 | +140.1% | COM | 10806X102 |
| FENC | FENNEC PHARMACEUTICALS INC | 112,434 (-8.6%) | $866 (-24.8%) | 4.5% | $8.27 | -0.7% | COM | 31447P100 |
| — | MERSANA THERAPEUTICS INC | 100 (-99.6%) | $3 (-98.6%) | 0.0% | $7.76 | — | COM | 59045L205 |
| RGNX | REGENXBIO INC | 26,600 (-53.9%) | $383 (-31.3%) | 2.0% | $15.56 | -19.9% | COM | 75901B107 |
| ARDX | ARDELYX INC | 128,650 (-21.0%) | $750 (-16.4%) | 3.9% | $1.61 | +245.3% | COM | 039697107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 36,000 (-34.5%) | $756 (-10.6%) | 3.9% | $20.81 | -16.2% | COM | 87164F105 |
| IRON | DISC MEDICINE INC | 8,100 (-23.6%) | $643 (-8.2%) | 3.3% | $49.93 | +69.2% | COM | 254604101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 67,500 | $890 | 4.6% | $52.12 | -77.4% | CLASS A ORD | 61559X104 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 42,000 | $391 | 2.0% | $6.88 | +21.4% | COM | 23954D109 |
| SPRB | SPRUCE BIOSCIENCES INC | 1,000 | $87 | 0.5% | $213.95 | -49.9% | COM NEW | 85209E208 |
| RPRX | ROYALTY PHARMA PLC | 21,400 | $827 | 4.3% | $36.20 | +5.3% | SHS CLASS A | G7709Q104 |
| KURA | KURA ONCOLOGY INC | 46,000 | $478 | 2.5% | $7.13 | +47.2% | COM | 50127T109 |
| CMPS | COMPASS PATHWAYS PLC | 58,000 | $400 | 2.1% | $5.73 | — | SPONSORED ADS | 20451W101 |
| BNTC | BENITEC BIOPHARMA INC | 62,000 | $835 | 4.3% | $9.63 | +43.5% | COM NEW | 08205P209 |
| RCKT | ROCKET PHARMACEUTICALS INC | 86,000 | $302 | 1.6% | $3.15 | +8.7% | COM | 77313F106 |